Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.
about
De novo synthesis, uptake and proteolytic processing of lipocalin-type prostaglandin D synthase, beta-trace, in the kidneysBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseEnzymes of the cyclooxygenase pathways of prostanoid biosynthesisStructural Basis of the Catalytic Mechanism Operating in Open-Closed Conformers of Lipocalin Type Prostaglandin D SynthaseChaperones of F1-ATPaseHigh-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthaseThe neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteinsNMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavityIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseLipocalin-type prostaglandin D synthase scavenges biliverdin in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway.Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid depositsNeuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effectsFibrinogen has chaperone-like activity.Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.Plug-based microfluidics with defined surface chemistry to miniaturize and control aggregation of amyloidogenic peptides.The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.Biosensor-based label-free assays of amyloid growth.Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Association of lipocalin-type prostaglandin D synthase with disproportionately enlarged subarachnoid-space in idiopathic normal pressure hydrocephalus.Positive and negative effects of prostaglandins in Alzheimer's disease.Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids.Biomarkers in Sporadic and Familial Alzheimer's Disease.Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.Sex-Related Differences in Rat Choroid Plexus and Cerebrospinal Fluid: A cDNA Microarray and Proteomic Analysis.Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disordersA Novel Plasma Based Biomarker of Alzheimer's Disease.A G protein-coupled receptor and the intracellular synthase of its agonist functionally cooperate.Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence.Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation.A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c.Cerebrospinal fluid proteomics reveals potential pathogenic changes in the brains of SIV-infected monkeys.Hippocampal neuronal cyclooxygenase-2 downstream signaling imbalance in a rat model of chronic aluminium gluconate administration.Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo.
P2860
Q24312883-3600F543-3B06-4D54-9FEC-EEBE6FEB7A4DQ24622136-D3735C53-DE5A-439C-82FC-27C2C8FAB727Q24630614-6885516C-E4E9-42FB-95F6-021E1DEE24A1Q27643949-543296B3-1EE5-45F1-A5B3-6E3356CBCEB1Q27655012-FA8C720D-9E79-41F8-B776-168774B1D779Q27694692-B0ECA6E1-F688-46CD-B4AB-678F48BA8CB1Q28279676-34F04EEC-8CEC-4C5F-A632-EE14C4FFDE88Q28506812-2E9160C4-E440-447A-9334-E78D953B441CQ28743561-6A1652FC-E4DE-41D4-98DB-FFE9895D6163Q34153484-F2798094-228F-4888-AE91-E12348953BFFQ34508284-4A1A11D7-1BE1-4A17-A981-1B38DB9305F8Q34634623-B51FC605-8BF8-4F52-8057-8921A60E00E5Q34671631-897734CA-CA18-4E95-81F4-A34E91DB0A4CQ34933261-5A38D278-4833-41B4-A0A3-2738177C1DC7Q34960461-EF5799AB-52FD-48BF-BA03-E11F0B2D200FQ35842012-EC1DCCDF-494B-41C7-8DE2-31D9281C4D75Q37144717-7E5699D1-ED24-49B6-AE67-5FBA7CDC66A1Q37157835-77C64D16-5DFF-4BEF-82BE-DFD9D714C8FBQ37175261-3FB14B53-A62C-471E-996E-C8190E8D7F14Q37232866-8CDEB6C7-158F-4637-A68D-CC0D4C624567Q37269299-C0DB72F6-BF68-491C-8355-F94FDC52DF33Q37518246-56714B9E-D6E4-4AD4-9730-56527FEC3B88Q37678539-27454025-86BB-4302-9C5A-1B303927E489Q37710507-F746674E-5208-4DE5-B6FE-E6EAD790C50EQ38132922-0AC6377D-CE37-4BFA-98F2-ACF36DD924E6Q38193833-A1DBABE3-68DD-45F0-BFE9-C68EC81DFE82Q38592041-6D0A0793-E715-45EF-B1D1-2BE34ADC4BE2Q39449759-989270EF-728F-4A3F-8C5F-4495CE935C7FQ39849130-7FC47170-4FA1-4CE0-BD0B-994CA0F160B9Q40275476-388D3101-87C5-4BA3-9F15-8D19C36198B6Q40663824-8E8DBC0F-1D5C-4EE6-8C25-3A6A2E0301BCQ41325603-F0137516-6C89-4257-B88A-FBB992945B4BQ41910497-C82ADAAE-97D8-4C3C-99B8-7DAF43593EB6Q42576079-E3A50C76-96B2-47C1-A2DE-3DEA2D0B65AFQ42581400-183A4FE0-2EA9-4DF1-8C8D-9AE04505FFDAQ42795210-AC49AB92-661B-46DC-8EF3-851607D5B173Q42829127-242638CA-7A54-4288-BCD1-14514E51383BQ42979507-B19F8171-435A-406B-843C-8CB08B05FDCEQ43157877-1771CB38-DB76-46D5-B717-322958740A2EQ43171502-87B6D87F-2608-49E3-93E9-69D56718C0CE
P2860
Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@ast
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@en
type
label
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@ast
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@en
prefLabel
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@ast
Lipocalin-type prostaglandin D ...... in human cerebrospinal fluid.
@en
P2093
P2860
P356
P1476
Lipocalin-type prostaglandin D ...... e in human cerebrospinal fluid
@en
P2093
Ikuko Mohri
Issay Okazaki
Keiichi Ozono
Kosuke Aritake
Masako Taniike
Shigeo Murayama
Tadato Ban
Takahisa Kanekiyo
Wei-Min Qu
Yoshihiro Urade
P2860
P304
P356
10.1073/PNAS.0701585104
P407
P50
P577
2007-04-02T00:00:00Z